Business NewsPR NewsWire • Shire and Santaris extend their strategic alliance to discover and develop LNA-drugs in the rare genetic disease field

Shire and Santaris extend their strategic alliance to discover and develop LNA-drugs in the rare genetic disease field

Shire and Santaris extend their strategic alliance to discover and develop LNA-drugs in the rare genetic disease field

HOERSHOLM, Denmark and SAN DIEGO, Aug. 23, 2013 /PRNewswire/ -- Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that its long term partner, Shire has extended the...

View More : http://www.prnewswire.com/news-releases/shire-and-santaris-extend-their-strategic-alliance-to-discover-and-develop-lna-d...
Releted News by prnewswire
Shire and Santaris extend their strategic alliance to discover and develop LNA-drugs in the rare genetic disease field
VStock Transfer to Co-Sponsor upcoming National Investment Banking Association Conference in New York
FSLogix to Showcase New Application Visibility Tool at VMWorld
Newshosting Announces v1.5.0 Newsreader Release